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Abstract
The research presented here demonstrates a halogenation reaction for pyrazoles
from the generation of electrophilic halogens through a reaction between halide anions
and Oxone®. Halogenation occurs at the 4-position, which is the most nucleophilic atom
of the heterocycle. The sodium halide salt and Oxone serve as the halogen source in an
electrophilic aromatic substitution. Oxone is a water-soluble, relatively innocuous reagent
produced by DuPont that makes this reaction environmentally friendly. The reaction
functions with good yields on a wide scope of substrates, works best without a cosolvent, is performed at room temperature, and requires short reaction times. These
factors, along with its operational simplicity and ease of purification make this reaction
highly valuable.
To demonstrate the utility of the reaction, a concise synthesis of the natural
product withasomnine was undertaken. Withasomnine is a compound isolated from the
flower withania somnifera and is a popular target for total syntheses involving pyrazoles.
Our synthesis is completed in five steps from pyrazole. A halogenation and subsequent
Suzuki-Miyaura cross-coupling reaction couples a phenyl ring to the 4-position.
Alkylation at position 1 using 3-bromopropanol followed by formation of the xanthate
ester enables a radical-initiated cyclization that forms the fused ring connecting to the 5position of pyrazole. Reaction sequence and conditions were explored and optimized and
are presented here.
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INTRODUCTION

Project Conception

Dapoxyl sulfonic acid (DSA) is a fluorescent molecule that can be efficiently
incorporated into a polymeric matrix. A project initiated by the Kneas research group
sought to use DSA as a fluorescent probe in a hydrogel-based humidity sensor that swells
in response to absorbed water molecules. An effective synthesis of DSA, desirable due to
its high cost and opportunities for derivatization, required a cyclization reaction to form
an oxazole in order to bring the two components of DSA together. Péréz et al. developed
a regioselective oxazole cyclization mediated by a copper catalyst and Scheme 1 shows
the catalyst used that contains a tridentate brominated pyrazole ligand.1-2 4-Bromo-3,5dimethylpyrazole is commercially available, but the corresponding chloropyrazole was
not. Given the need for halogenated pyrazoles, a search in the chemical literature
revealed several different methods of 4-halogenation, some with green characteristics.3-7
Herein, these methods will be reviewed for their approaches to pyrazole 4-halogenation
and respective advantages and disadvantages, in the context of green chemistry.
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Scheme 1: Regioselective oxazole cyclization as proposed by Péréz et al.1

The United States Environmental Protection Agency (US EPA) outlines twelve
principles of “Green Chemistry,” which advocates for sustainable principles. Among the
12 principles of green chemistry are preventing waste, designing non-hazardous
syntheses, using safe solvents, increasing energy efficiency, and avoiding derivatives.8
Pike Research, a market intelligence firm, estimated in 2011 that the chemical industry
would save approximately $65.5 billion by 2020 through green chemistry initiatives.9
Scheme 2 shows a method for iodination proposed by Kim et al.3 The researchers
report extensive substrate scope in an aqueous solution, and limited innocuous
byproducts (water), simplifying purification. The reaction can be run at room temperature
in several hours to completion if the substrate is electron rich. However, this method has
only been applied to iodination, and although there was preference for monoiodination at
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the 4-position, the paper indicates that there may be problems with multiply-iodinated
byproducts.3

Scheme 2: A green iodination for pyrazole using iodine and hydrogen peroxide.

Zhao et al. have demonstrated a reaction that halogenates pyrazoles using Nchlorosuccinimide and N-bromosuccininmide to form the respective chloropyrazoles and
bromopyrazoles, as shown in Scheme 3.4 Most of the reactions can be completed in a few
hours, performed at room temperature, and completed effectively with water as a
solvent.4 However, the reaction is undesirable due to the dependence of some reactions
on using CCl4 as a solvent, which is generally expensive and toxic. If a project’s goals
include reducing costs, environmental impact, and the overall amount of toxic substances
in the lab, this method may not be ideal.

Scheme 3: A halogenation reaction using N-halosuccinimide.
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One particular pyrazole transformation (Scheme 4) demonstrated by Li et al. is
extremely versatile at completion times of approximately ten minutes, using a
combination of N-bromosuccinimide, an acidic solvent (CH3COOH, 5% HNO3 in
CH3COOH, or trifluoroacetic acid), and microwave irradiation.10 The reaction yields
exceed 67%, where the lowest-yielding pyrazoles are highly electron-poor. The electronpoor substituents include esters and halogenated phenyl rings.10 Whereas many other
methods have shown very low yields for these types of compounds, this method has
proven practical with unfavorable substrates, such as those that are electron-poor. The
only downsides to this method are the need for a highly acidic solvent, and the necessity
of using a microwave which is not highly energy efficient.

Scheme 4: Pyrazole halogenation promoted by microwave irradiation.

In summary, multiple green methods for pyrazole halogenation are known, and
some have advantages that surpass the limitations of typical electrophilic aromatic
substitution reactions. However, few meet the desirable criteria of inexpensive reagents
and operational simplicity.The methods exhibit some adherence to the US EPA’s
principles of green chemistry but are limited somewhat by their use of potentially
hazardous solvent systems.8 A method for the halogenation of pyrazoles that has wide
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substrate scope, avoids toxic and expensive solvents, and can be performed at room
temperature to afford high rates of conversion was still desired.

Pyrazoles and their Importance

Pyrazoles are a well-studied class of aromatic heterocycles that are relatively rare
in natural products, yet have been extensively developed in pharmaceutical applications
and agrochemicals. Pyrazoles are structural isomers to imidazoles, differing in the
placement of N atoms in the 5-membered ring. Pyrazoles and imidazoles are often
considered analogous in reactivity, and many comparisons are drawn between the two.11
Pyrazole is considered a “π-excessive” heterocycle, suggesting it is relatively electronrich, making for a good aromatic nucleophile. In Figure 1, the pyrazole ring positions are
labeled – position 1 holds the acidic proton of the heterocycle, while position 4 is the
most nucleophilic carbon atom of the ring, which is supported by experimentation with
electrophiles as well as electronic structure computations using methods focused on the
linear combination of atomic orbital/molecular orbital basis functions.11

Figure 1: The structure of pyrazole, numbered ring positions with π-electron densities of
atoms and π-bond orders between atoms.11
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Pyrazole’s interesting properties as a highly nucleophilic, relatively polar
heterocycle lend to its applications in various pharmaceutical avenues. Antiinflammatory, antimicrobial, and even anticancer applications have been developed for
pyrazole derivatives.12-14 Celecoxib, commercially known as Celebrex, is an antiinflammatory and analgesic cyclooxygenase-2 inhibitor, typically prescribed for
rheumatoid arthritis and osteoarthritis.12 Pyrazofurin is a C-nucleoside antibiotic, and
functions as a competitive inhibitor to proteins involved in transcription and translation in
bacteria.14 Some pyrazole-based metal complexes are being explored for applications in
cancer treatment;PtCl2(pzH)2 is a platinum complex with similar antitumor activity to
cisplatin.12 The structures of these compounds are shown in Figure 2.

Figure 2: Examples of pyrazoles in medicine.

In addition to medicinal applications, pyrazoles have been incorporated in the
structures of agrochemicals. One example is the acaricide (referring to insecticides
designed to kill members of subclass Acari) Tebufenpyrad, commonly used to suppress
populations of the two-spotted spider mite Tetranychus urticae. The adaptation of T.
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urticae to Tebufenpyrad and other acaricides has prompted extensive derivatization.15
Fipronil is another pyrazole that is used as a seed coating formulation. The insecticide
protects corn and sunflower from wireworms and other soil insects, but it has been
hypothesized that uptake into the phloem of sunflower could be causing harm to
pollinating bees. A recent study by Raveton et al. suggested that radiolabeled Fipronil
may be taken up by transfer from roots into the phloem of sunflower.16 Strobilurins
constitute a class of antifungal chemicals by inhibition of Complex III in the electron
transport chain, stopping electron transfer from ubiquinol and cutting aerobic respiration.
Although Strobilurins are not commonly derivatized with pyrazole, a 2006 paper by Li et
al. demonstrates some of these derivatives and their antifungal activities. Tebufenpyrad,
Fipronil, and one such Strobilurin derivative with a broad spectrum of fungal growth
inhibition5 are shown in Figure 3.

Figure 3: The structures of Tebufenpyrad, Fipronil and a Strobilurin derivative.
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Pyrazoles in the MacKay Group
A recent discovery in our lab demonstrated a method to halogenate pyrazoles at
the 4-position. While this work is not the first instance of pyrazole halogenation, it is
unique because it uses Oxone® (a triple salt, 2KHSO5 · KHSO4 · K2SO4) and a sodium
halide salt, which are entirely water soluble, to result in the transformation. This reaction
is complete in several hours, operates at room temperature, and has tolerance to
functionality including allyl groups and aromatic systems. Oxone is used in
stoichiometric quantities to produce electrophilic halogens in situ from halide anions by
oxidation. Katie Olsen set up the basic methodology for this reaction, including the bulk
of substrate scope, solvent experimentation, and characterization of novel products.17
The very recent applications of pyrazoles in pharmaceuticals and agrochemicals
bring the importance of the heterocycle moiety into perspective. A total synthesis would
then showcase the importance of a pyrazole halogenation, and demonstrate the recentlydeveloped method in the context of a natural product synthesis. Pyrazole-containing
natural products are relatively limited in number due to the rarity of N-N bond-forming
reactions in biosynthetic pathways. To further limit the available options, the number of
4-subsituted pyrazoles that could be synthesized using a bromopyrazole intermediate is
an even smaller quantity. One option that would facilitate such a proof of concept is
withasomnine.
Withasomnine (structure and derivatives in Figure 4) is a compound extracted
from the flower Withania somnifera and is traditionally used in holistic Ayurvedic

8

medicine.18 Withasomnine has been clinically demonstrated to be an analgesic as well as
a circulatory and central nervous system depressant.19 Withasomnine is a relatively
popular target for total synthesis due to its structural simplicity and its presence as one of
the very few pyrazole-containing natural products. The product was isolated by Schröter
et al. in 1966, and first synthesized by Morimoto et al. in 1968.13, 19-28

Figure 4: The structure of withasomnine and related natural product analogs.

With a novel method of pyrazole halogenation, the research question was centered
around the possibility of synthesizing withasomnine from pyrazole, by employing a
synthetic route specific to pyrazole chemistry. It was hypothesized that a concise
synthesis could be sufficiently modular to be applied to the synthesis of biologically
relevant and useful analogues. Additionally, if the reaction could be applied to a
functionalized substrate in the middle of a synthesis, it may show the reaction’s
versatility.
Different synthetic methods have been developed for pyrazoles in recent years.13
Choosing to start from pyrazole narrows the field of available transformations to those
that are specific to pyrazole, demonstrating the applications of these methods. Most
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syntheses of withasomnine are concise, so in order to keep up to those standards, this
approach will attempt to use no more than five transformations to produce withasomnine.
A concise synthesis should be feasible by utilizing the halogenation described previously
to lead into a Suzuki-Miyaura Coupling reaction, in addition to alkylating the pyrazole at
position 1, and then using a radical precursor xanthate ester to generate a radical, which
will cyclize onto the 5-position of the ring in an intramolecular reaction.

Previous Syntheses of Withasomnine
After withasomnine was first isolated from withania somnifera by Schroter et
al.in 1966,18 numerous syntheses were later published. The first complete synthesis was
reported by Akira Morimoto in 1968, which covered three methods to produce
withasomnine from 4-phenyl-3-hydroxymethylpyrazole (Scheme 5), indole (Scheme 6),
and 4-phenyl-3-pyrazolepropionic acid (Scheme 7).
Morimoto’s first reported synthesis from 4-phenyl-3-hydroxymethylpyrazole
(commercially available), shown in Scheme 5, follows a strategy of lengthening the
existing alkyl chain by a malonic ester synthesis to 4, acidic hydrolysis and
decarboxylation to 5 to limit the alkyl chain length to three carbon atoms, and to later
cyclize the fused 5-member ring. The resultant carboxylic acid is reduced to an alcohol
(6), the alcohol is exchanged for a chloro- substituent to form 7, and the ring closure is
completed using a strong base to give withasomnine, 1.20 This synthesis was completed
in six steps, and the approach here appears to be the most simplistic, consisting of SN2
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reactions and decarboxylation. From a green chemistry perspective, this synthesis is
limited because it is six steps, and it uses harsh reagents like LiAlH4 and SOCl2. Thionyl
chloride generates toxic SO2 as a byproduct. In both cases, the reagents are used in
stoichiometric amounts. Currently, lithium is an element becoming increasingly rare, as
demand for use in batteries increases around the globe. The principles of green chemistry
include using renewable feedstocks, so lithium use as a reagent should be avoided where
possible.

Scheme 5: Synthesis of withasomnine from 3-hydroxymethyl-4-phenylpyrazole (2).

Morimoto’s second synthesis (Scheme 6) begins with indole, and acylation is
effected via a Vilsmeier-Haack reaction to form 9. A selective transformation attributed
to a publication by Alberti et al. in 1957 that describes the use of NH2NH2∙H2O to convert
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3-acylindoles to 4-(2’-aminophenyl)-pyrazoles is used to form 10.29 In one path, the
amine group is removed by reductive deamination to 11, the ether is exchanged for a
bromo substituent in 12, and base-catalyzed ring closure completes the synthesis. In the
other path, the ether is exchanged first to form 13, basic reflux closes the ring to 14, and
reductive deamination completes the sequence.20 This synthesis is five steps, and is more
efficient because it begins from a common heterocycle and uses the Vilsmeier-Haack
reaction and ring transformation as central steps. This pathway is a slight improvement
over Morimoto’s first synthesis in terms of green chemistry by reducing steps, but it uses
very hazardous reagents. POCl3 is toxic and used stoichiometrically in the VilsmeierHaack reaction, hydrazine is highly toxic and reactive, and remaining steps use highly
acidic or basic conditions for group removal and cyclization.
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Scheme 6: Synthesis of withasomnine from indole, expressed in two paths.

The final synthesis (Scheme 7) outlines a second path from one of the
intermediates (5) of the first synthesis. In this case, the formation of an acyl chloride (15)
using thionyl chloride is performed first, followed by a lactam formation to effect ring
closure using trimethylamine. Following ring closure, a Clemmensen reduction reduces
16 to form withasomnine as a minor product. Using the first synthesis to generate the
starting material, this pathway consists of six steps and is marginally more complicated
than the first synthesis. Formation of the acyl chloride and cyclization using triethylamine
could be performed in one pot, which may simplify performing the synthesis, but the
Clemmensen reduction appears to be a limiting factor in this path’s total efficiency.
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Morimoto’s third pathway is one step longer than the first synthesis, and uses SOCl2 and
a Zn/Hg amalgam. As mentioned before, chlorination by SOCl2 generates SO2 which is
toxic, and mercury is well-known to be toxic. Additionally, amalgam preparation is a
hazardous process involving the dropwise addition of mercury to a heated metal. Mercury
is not consumed by the reaction, so it must also be disposed of appropriately.

Scheme 7: Synthesis of withasomnine from 4-phenyl-3-pyrazolepropionic acid.

A notable follow-up to Morimoto’s syntheses of withasomnine is detailed in a
publication by Kulinkovich et al. in 1996 (Scheme 8). Kulinkovich’s strategy consisted of
building an α,β-unsaturated ketone from ethyl 4-chlorobutanoate (17). Similar to
Morimoto’s synthesis of withasomnine from indole,20 this synthesis used hydrazine to
construct the pyrazole ring with the chloroalkane chain pre-installed in 21. Cyclization of
the fused ring proceeds by a simple SN2 reaction to form 22. Interestingly, Kulinkovich
uses molecular bromine to halogenate the pyrazole, similar to the method proposed here –
the presence of weak base serves to scavenge the acidic HBr formed. A Grignard reagent
is coupled to the halopyrazole in a nickel-catalyzed reaction.25 Although this synthesis is
complicated by how many steps it takes in preparing the α,β-unsaturated ketone 20, it
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approaches pyrazole construction in a manner that avoids most complications with its
reactivity. The bromination method to form 23 described here simply shows that pyrazole
can be halogenated by the presence of an electrophilic molecular halogen species.
Additionally, the Grignard-like coupling reaction is used to couple pyrazole to the phenyl
ring.20, 25 The approach in Kulinkovich’s strategy represents common methods for
substituted pyrazole synthesis, which use hydrazine and a 1,3-dipole (in this case, the α,βunsaturated ketone).13 This synthesis is limited in terms of green chemistry because it is
relatively long and uses multiple hazardous reagents. The pathway includes highly
reactive Grignard reagents, toxic molecular bromine, and highly toxic and reactive
hydrazine all as stoichiometric reagents. C-C bond coupling is achieved in the final step
using a harsh reagent, rather than a selective catalyst. Atom economy in the synthesis is
poor, as very few of the reagents are incorporated into the structure of the final product.
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Scheme 8: Total synthesis of withasomnine described by Kulinkovich et al.25

Potáček et al. also reported a total synthesis (Scheme 9) for withasomnine that
constructs the pyrazole using the Kulinkovich strategy, but with improvements on yield
(35% total synthetic yield from 10%). This synthesis proceeds from 17. A series of
preparative steps allows ring construction of the pyrazole, alkylated at position 3 (21).
Ring closure is completed in basic conditions, bromination is performed with Nbromosuccinimide (NBS, using a method similar to that of Zhao et al.) to form 23, and
the resultant protected pyrazole is coupled to the phenyl ring by a Suzuki-Miyaura crosscoupling.21 The work presented by Potáček is an improvement on the Kulinkovich
strategy due to its use of an NBS bromination and a Suzuki coupling. However, the ring
construction strategy still limits the method in terms of the number of steps. By
performing a Suzuki coupling on an unprotected pyrazole, the phenyl ring can be
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installed before the fused ring is made, making the synthesis more straightforward, and
reducing the number of steps. Potáček’s synthesis is an improvement over Kulinkovich’s
synthesis in terms of green chemistry as well. The pathway eliminates one instance of
using a Grignard reagent in place of a stable and innocuous boronic acid, eliminates one
instance where molecular bromine is used for NBS, and has a significant increase in
synthetic yield which makes the pathway efficient. However, it still uses a Grignard
reagent, molecular bromine, and hydrazine in stoichiometric amounts, and is the same
number of steps as the Kulinkovich synthesis. Due to the stepwise strategy of the
synthesis, atom economy remains poor.

Scheme 9: Synthesis of withasomnine from ethyl 4-chlorobutanoate described by
Potáček et al.21

A method presented by Allin et al. in 2002 describes a more concise total
synthesis using more modern synthetic advancements. The method, shown in Scheme 10,
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begins with 4-bromopyrazole (24). The synthesis proceeds by protection with tosyl
chloride to form 25, and subsequent Suzuki-Miyaura coupling to 27. Deprotection
removes the tosyl group at position 1, allowing alkylation with a with a phenylselenide
radical precursor to form 29. A radical-initiated cyclization closes the ring to form
withasomnine.23 Allin’s synthesis is the most green of the pathways reviewed: it is five
steps, high-yielding, and avoids toxic reagents for the most part. However, the pathway
uses the toxic radical initiator SnBu3H and uses a 1-protected pyrazole for its Suzuki
coupling, which is wasteful in terms of atom economy and forming derivatives.23 Despite
these issues, the Allin synthesis stands as using the most innocuous reagents of the
literature pathways, with the fewest steps and highest atom economy.

Scheme 10: Synthesis of withasomnine from 4-bromopyrazole.

The previously explored syntheses take different approaches to the synthesis of
withasomnine, include starting from substituted pyrazoles, construction of a 1,3-dipole to
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synthesize a substituted pyrazole, and beginning from a halogenated pyrazole. The
synthetic strategy presented in the current work takes advantage of several
transformations that have been extensively developed in the recent past. The synthetic
strategy hinges around two major transformations to install the distinct features of
withasomnine: a palladium-catalyzed cross-coupling to attach a phenyl ring, and a radical
cyclization to install a fused ring.

Our strategy follows the logic of the Allin

synthesis, but seeks to improve it in terms of atom economy by avoiding protection steps
that create unnecessary waste, and utilizing an innocuous radical initiator. Herein, the
methodologies behind the Suzuki coupling and radical-initiated cyclizationare reviewed,
with the intent of atom economy improvement and the avoidance of toxic reagents.

The Suzuki-Miyaura Cross-Coupling
Akira Suzuki won the Nobel Prize in Chemistry in 2010 along with Richard F.
Heck and Ei-ichi Negishi for their combined contributions in palladium-catalyzed cross
couplings. Suzuki developed carbon-carbon bond forming reactions using halides and
organoboron coupling partners, and the method rapidly found applications in organic
synthesis and the development of pharmaceuticals.30 Through mechanistic analysis, it
was determined that the catalytic cycle proceeds through an oxidative addition of the
carbon-halide bond across Pd(0). Transmetallation results in exchange of the halide for
the organoboron species, expelling the boronate and halide together. Finally, reductive
elimination releases the newly coupled species and returns the neutral palladium catalyst.
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Suzuki couplings have been applied to many different types of halopyrazoles, but there is
limited precedent for unprotected –NH pyrazoles.13 The catalytic cycle, when concerning
phenylboronic acid and halopyrazole, is shown in Figure 5.

Figure 5: The catalytic cycle of the Suzuki-Miyaura cross coupling.

Considering that oxidative addition is the first step, and often treated as the step
that is rate-limiting in the catalytic cycle, the success of the reaction is most likely
dependent on electronic effects from the ligands coordinated to the palladium center.
Success of the reaction is limited by the attraction of deprotonated pyrazole to palladium.
This hypothesis is confirmed in a publication by Buchwald et al. The inhibitory effect of
several unprotected N-rich heterocycles is explored, and experiments show that 4substituted pyrazoles administered as an additive tend to be highly inhibiting. This
inhibition is caused by a dimerization that essentially suspends the catalyst, making it
ineffective. 31 If the pyrazole is too nucleophilic relative to the metal center, the
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unprotected lone pair on nitrogen will complex to palladium, causing dimerization in
which pyrazole acts as a bridging ligand between two palladium atoms. Therefore, the
addition of highly electron-donating ligands will be necessary to prevent this competing
interaction.
Beller et al. discovered new catalyst systems for deactivated aryl chlorides with
arylboronic acids,32 and their work has impacted a recent publication, by Tan et al.
exploring favorable conditions to cross-coupling reactions for unprotected
haloimidazoles. In addition to imidazoles, pyrazoles were explored. A ligand screen
showed that favorable conditions for these compounds required highly electron-rich
phosphines. Indeed, the most successful ligands were A-taPhos and CataCXium® A.33
The structures of these compounds, lending to their high electron-donating character, are
shown in Figure 6.

Figure 6: The CataCXium® A and A-taPhos ligands.

With the understanding from the mechanistic investigation by Buchwald et al.31
and the success of this ligand as demonstrated by Tan et al.33, it can be hypothesized that
the bulky and electron-rich ligand serves a twofold purpose – it allows the palladium
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center to outperform pyrazole as a nucleophile, preventing complexation, and it creates
steric hindrance that would make the inhibitory dimer less likely.

The Radical-Initiated 5-exo trig Cyclization
The radical cyclization proposed in our work has precedent in the synthesis of
withasomnine published by Allin et al. That synthesis used 1,1’Azobis(cyclohexanecarbonitrile), or ACCN, as a radical initiator, in order to cause
hydrogen abstraction of HSnBu3.23 Conditions for this transformation are shown in
Scheme 11.

Scheme 11: A radical initiated cyclization demonstrated by Allin et al.23

Following hydrogen abstraction, tributyltin radical would interact with the
phenylselenide group at the end of the alkyl chain, generating a primary radical. Another
common radical precursor in organic synthesis is the xanthate ester, which is likewise
fragmented by interacting with the tributyltin radical. Publications in recent years by Zard
et al. (Scheme 12) have shown various radical transformations using xanthate precursors
with a variety of radical initiators.34-37

22

Scheme 12: Several examples of xanthates being used as radical precursors in organic
synthesis, in methods published by Zard et al.34-37

Thus, the use of a xanthate as an alkyl radical precursor is advantageous due to
the flexibility of appropriate radical intiators and solvent systems. This flexibility in
initiators presents an opportunity to use greener alternatives than toxic SnBu3H, and the
xanthate group is an improvement on atom economy due to its relatively small size
compared to the phenylselenide group.
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In the next section, a new method for the halogenation of pyrazoles will be
explored. The new method is an intended improvement upon current methods in
adherence to the principles of green chemistry by using benign solvent systems,
innocuous reagents, and avoiding energy input entirely. This method will generate
electrophilic halogens in situ in order to make the handling of these carcinogenic species
negligible. Explored factors include the impact of co-solvent on reaction conversion, and
the scope of substrates for which the method is effective. With this method established, a
new total synthesis of the natural product withasomnine is explored. This approach uses
the least number of steps feasible in a straightforward total synthesis, enlisting the
methods that have just been reviewed.
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RESULTS AND DISCUSSION
Solvent Studies and Reaction Tolerance

Scheme 13: Reaction model used for co-solvent experiments.

Solvent experiments were performed in order to determine if a co-solvent was
appropriate for this reaction, and which co-solvent would work best. For this study, a
substrate was used that would be relatively nonpolar as to make any aqueous reactions
heterogeneous. In experiments where no co-solvent was used, a distinct layer of 1benzyl-3,5-dimethylpyrazole was visible that only dissolved with vigorous mixing.
Table 1: Co-solvent studies evaluated by conversion with 1H NMR.
Entry

Co-solvent

Time (h)

Conversion (%)

1

None

24

100

2

None

1

80

3

CH3CN

24

77

4

EtOAc

24

55

Solvent studies performed with 31 showed that the reaction was most effective
without a co-solvent. In all reactions, the same total volume was used. Where co-solvent
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was involved, the water and co-solvent were present in a 7:3 volumetric ratio. The use of
water as a reaction medium allows for the partial dissolution of oxone, but the substrate
remains in a separate phase. Regardless of the use of co-solvent, the reaction should
occur at the interface of these two layers. By diluting the interface with an organic
solvent and limiting the total amount of water to dissolve Oxone, the reaction
concentration can be considered to be diluted. Therefore, it seems reasonable to expect
that omitting nonpolar solvent would increase yield. This result contrasted from the
original hypothesis which suggested that a nonpolar co-solvent could mediate the
heterogeneous reaction. Interestingly, however, the polar co-solvent appears only to limit
reaction efficacy. This finding disagrees with previous work, which was focused on
determining reaction efficacy based on yield, rather than conversion.
Table 2: Co-solvent studies evaluated by percent yield, performed by K. Olsen.17
Entry

Co-solvent

Time (h)

Yield (%)

Conversion (%)

1

None

1

N/A

65

2

CH3CN

2.5

62

81

3

Acetone

24

52

83

4

THF

24

45

70

5

CH2Cl2

24

18

48

6

Toluene

24

24

42

7

EtOAc

24

70

75

The studies described in Table 1 contrast with that of Table 2, which were
performed by K. Olsen ’14. Originally, Olsen evaluated the effectiveness of the co-
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solvent based on product yield.17 In an effort to control reaction variables, the recent
experiments were all conducted over 24 h, were carried out in the same type of flask
using oven-dried glassware, and were carried out on the same scale. Furthermore, the
data were reported using percent conversion by 1H NMR as a basis of comparison to
remove the effect of product loss or any other source of variation in purification. Olsen’s
work suggested that EtOAc was the more effective solvent, and water was considered
because it had limited yield. The recent experiments demonstrated that water was more
effective, even on a limited amount of time. However, the nonpolar solvents were not
explored, as NMR conversions between the two studies generally agreed, given some
variability, and Olsen’s work did not suggest that the co-solvents dichloromethane,
toluene, or tetrahydrofuran would be highly effective.17

Scheme 14: Substituent placement in substrate scope experiments.
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Table 3: Substrate scope of the electrophilic halogenation of pyrazoles using NaX and
Oxone.
Entry

X

R1

R2

R3

Co-solvent

Yield (%)

Conversion
(%)

33a

Cl

-CH2CH3

-CH3

-CH3

None

50

100

33b

Br

-CH2CH3

-CH3

-CH3

None

11

95

34a

Cl

-CH2CH=CH2 -CH3

-CH3

None

36

78

34b

Br

-CH2CH=CH2 -CH3

-CH3

None

17

51

35a

Cl

-H

-H

-Ph

EtOAc

71

90

35b

Br

-H

-H

-Ph

EtOAc

73

85

36

Br

-H

-H

-CH2Ph

None

86

100

32

Cl

-CH3

-CH3

-CH2Ph

None

57

100

24

Br

-H

-H

-H

None

80

100

Alkyl substituted substrates generally had high rates of conversion (33a, 33b, 32,
36). The high conversion may be attributed to the substituents increasing the overall
electron density of the ring, which facilitates the electrophilic aromatic substitution
reaction. However, yield among the ethylpyrazoles is low, most likely due to volatility
preventing purification. Product isolation using column chromatography requires
concentrating the product in vacuo to remove solvents. The phenylpyrazoles (Entries 35a
and 36b) are apparently significantly less volatile than the ethylpyrazoles, improving
yield but having similar product conversion. One of the more problematic classes of
substrates were the allyl pyrazoles (Entries 34a and 34b) which should be limited in
conversion due to the competitive reactivity between position 4 of the pyrazole and the
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alkene. Low conversions among these reactions confirm this hypothesis, and secondary
products were difficult to remove from the product mixture, which further lowered yield.
Competition between aromatic substitution and alkenyl substitution is a limitation of the
substrate, as would be expected.
Substrates with aromatic substitution (Entries 35a, 35b, 36, 32) regardless of
conjugation did not show byproducts that were a result of competition, and yields were
generally high, in the range of 57% and above. This could be attributed to a phenyl ring
having more aromatic character than a pyrazole, resulting in a higher activation energy to
halogenate. When the phenyl ring is conjugated with the pyrazole ring (Entries 36, 32),
there is also no type of distribution of nucleophilicity into the conjugated ring, as
suggested by the high conversions of these substrates into the product.
It should be worthwhile to more thoroughly examine and repeat some of the
substrate experiments in order to get a more thorough perspective of substrate scope, and
exactly what compounds are tolerable to what degree. Modifications may include
improving workup or eliminating co-solvent when it was originally included, in order to
improve yield. Additionally, it may be important to isolate variables like reaction time in
order to compare effectiveness on a level field.
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Total Synthesis of Withasomnine
The main goal of the synthesis was to demonstrate the use of a pyrazole
halogenation in a total synthesis. The specific goal of the total synthesis of withasomnine
was to couple a phenyl ring to position 4 of pyrazole and to attach a 5-member fused ring
connected at positions 1 and 5. Attaching the phenyl group may be effected by the
NaX/Oxone method (X= Br) followed by Suzuki-Miyaura cross-coupling of
phenylboronic acid (W= B(OH)2). Attaching the fused ring system would be completed
by alkylation (Y= Cl, Z= OH), formation of a xanthate ester radical precursor (Z=
OCSSCH3), and radical-initiated 5-exo-trig cyclization.

Figure 7: General retrosynthetic strategy of the total synthesis of withasomnine from
pyrazole.
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Figure 8: The first retrosynthetic pathway attempted for the total synthesis of
withasomnine from pyrazole.

The initial plan was to set up the reaction sequence such that alkylation and
xanthate formation would precede the bromination and Suzuki steps, therefore showing
the utility of the bromination reaction. After brominating, the Suzuki reaction would
install the phenyl ring, with the added benefit of using the alkyl chain as a pseudo
protecting group to prevent N-coordination of the pyrazole to the Pd catalyst. The radical
cyclization would benefit from the resulting conjugated phenyl ring in stabilizing the
radical intermediate, improving yield.
This approach, presented in

31

Scheme 15 was eventually abandoned because of low yields in the halogenation
reaction (21%), possibly due to competition from the xanthate ester acting as nucleophile.
Additionally, xanthates are understood to be particularly sensitive to acidic aqueous
conditions, in which the presented halogenation method operates. Either effect may have
contributed to the low yield of the desired product 38. This complication, which was not
anticipated, prevented using the bromination reaction on a functionalized substrate. While
this was a simple change in terms of reaction sequence, it was a significant setback in
terms of the original hypothesis of this study, which proposed that the bromination could
be showcased as an intermediate step in the synthesis of withasomnine. Regardless of the
setback, this problem helped refine the synthesis into a more successful and efficient
pathway.

Scheme 15: Progress on the first attempt at the synthesis of withasomnine.

In light of the unexpected problems with halogenation in the presence of a
xanthate ester, the second approach to withasomnine was planned such that halogenation
would precede functionalization. The remaining transformations: alkylation and xanthate
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ester formation to 38, Suzuki-Miyaura coupling to 37, and radical cyclization, to 1 would
follow.

Figure 9: The second retrosynthetic pathway proposed for the synthesis of
withasomnine.

Formation of xanthate ester 38 was successful on the halogenated pyrazole 24 in
55% yield (Scheme 16). The product 42 was not isolated due to it degrading on silica.
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Scheme 16: Progress on the second route to withasomnine synthesis.

Pursuit of the coupling was complicated and unprecedented in the literature. The
first attempt at this transformation used a catalyst system that was similar to what was
shown in the introduction (Beller et al.)32 for an unprotected NH pyrazole (Scheme 17).

Scheme 17: Reaction scheme and conditions for the Suzuki coupling of the xanthate
ester product, in the presence of aqueous basic conditions.
The basic aqueous conditions of this reaction appeared to cause a hydrolysis of
the xanthate ester, resulting in a mix of products, which did not appear to contain the
desired product as evidenced by 1H NMR. The next attempt (Scheme 18) would eliminate
water from the process, to keep the xanthate ester group intact.
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Scheme 18: Reaction conditions for the Suzuki coupling of the xanthate ester in dry
conditions with triphenylphosphine as the catalyst ligand.

The attempt (Scheme 19) also did not appear to form the product, presumably due
to the insolubility of the base, resulting in the omission from the catalytic cycle. Here,
triphenylphosphine was used as ligand, instead of CataCXium A, because previously
reported catalyst systems for the protected coupling typically included the cheaper and
simpler triphenylphosphine ligand.22 Although this was a multi-variable change in steps
forward, the steric bulk of the alkyl chain xanthate group made it seem as though the
bulky adamantly groups would not be needed from the perspective of steric hindrance.

Scheme 19: Reaction conditions for the Suzuki coupling of the xanthate ester in dry
conditions with triphenylphosphine as the catalyst ligand, and the organic base HMDS.

The problems with aqueous bases were avoided by using potassium
hexamethyldisilazide (Scheme 28), which was soluble in THF. However, this reaction did
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not appear to produce the desired product. The reaction returned primarily starting
material and byproducts, which were not identified due to time constraints. This
confirmed that an aqueous base is required for the Suzuki catalytic mechanism.

Figure 10: The third and working retrosynthetic pathway for the total synthesis of
withasomnine.

The previous routes demonstrated two major obstacles. First, the xanthate ester
was not highly compatible with the halogenation method presented in this work. Second,
the xanthate ester was sensitive to aqueous basic conditions, which were necessary for the
Suzuki coupling. The final route attempted for withasomnine synthesis was planned in
the order of halogenation, coupling, alkylation, xanthate ester formation, and cyclization.
The intent here is to avoid the complications of the xanthate ester such that the step
following xanthate ester formation would be the cyclization itself. Having the xanthate
and alkyl chain installed pre-Suzuki was disadvantageous - alkylation increases electron
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density which is unfavorable to the Suzuki catalytic cycle’s oxidative addition step, the
xanthate ester could complex to palladium, and the aqueous basic conditions could lead
to xanthate hydrolysis. The original strategy of using the conjugated phenyl ring to
stabilize a radical cyclization could be preserved, because installation of the phenyl ring
would still precede the cyclization. The difficulty in this approach appeared to be
performing the Suzuki coupling on an unprotected pyrazole. The catalyst system
determined by Beller et al. and developed by Tan et al.33 described the necessary
transformation in the presence of the unprotected halopyrazole.
The halogenation reaction was effective at producing 24 in 80% yield. Effecting
C-C bond formation in the following step was a formidable task. Suzuki-Miyaura crosscoupling of unprotected haloimidazoles and halopyrazoles is a problematic reaction, and
most syntheses (including Allin et al., who uses a similar synthetic strategy23) use an Nprotection in order to use simpler catalyst systems.26, 33, 38-42 A method by Tan et al.33
overcomes the problems of unprotected azole couplings identified by Buchwald et al.31
and prevents the need of a protecting group at position 1 of the pyrazole, making a
significant improvement in terms of atom economy over the Allin synthesis.23

Scheme 20: Suzuki-Miyaura cross-coupling with phenylboronic acid on 4bromopyrazole.
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The coupling of 24 with phenylboronic acid was designed based on an identical
transformation performed by Tan et al.33 However, there were some discrepancies
between what was presented in the body of the paper concerning catalyst loading, and the
actual catalyst loading reported in the experimental section. This caused some difficulty
in reproducing the results of Tan’s work. With some modifications, increased catalyst
load was able to drive the reaction forward to the formation of 44. In all attempts, a
byproduct, biphenyl (45), was identified by its GC-MS molecular ion and distinct
fragmentation pattern from the electron-ionization ion source.
Table 4: Effects of catalyst loading on Suzuki-Miyaura cross-coupling of phenylboronic
acid on 4-bromopyrazole.

a

Entry

Pd(OAc)2
(mol %)

CataCXium®
A (mol%)

PhB(OH)2
(equiv.)

Products

Yield
(%)

Time
(h)

1a

3.75

0.9

1.25

24, 45

N/A

24

2a

2.5

6

1.25

24, 45

N/A

24

3a

10

20

1.25

24, 44, 45

N/A

24

4b

10

20

1.25

44, 45

12

24

5b

5

10

1.25

24, 42, 45

51

72

6b

2.5

5

1.25

24, 44, 45

42

24

7a

2.5

5

1.75

24, 44, 45

N/A

24

Products worked up by filtration through celite. bProducts worked up by aqueous extraction.

Entry 1 represents the results of multiple attempts to form the desired product 44
explicitly using the experimental details from Tan et al.33 No desired product was formed,
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but starting material was retrieved along with biphenyl, the homo-coupling byproduct. In
Entry 2, the catalyst loading was varied to increase the amount of ligand relative to metal,
and likewise returned no product. Catalyst loading was increased drastically in Entry 3
which yielded 44, but the product was not isolated. To improve likelihood of isolating
product, reaction scale was increased threefold in entry 4.The reaction pressure vessel
size was the same, which increased pressure and diminished the amount of 24 present
such that it was not detected by GC-MS. Another difference between entries 3 and 4 was
that aqueous extraction was used in entry 4 instead of filtration through celite, assisting in
identification of the product by tlc. In entries 5 and 6, catalyst loading was decreased by
half in each step to reduce the use of an expensive ligand. Entries 5 and 6 produced the
product in high conversion, however in 6 there was a considerable amount of 24
remaining as detected by GC-MS. In Entry 7, it was expected that an increased amount of
the boronic acid reactant would result in complete consumption of 24. However, only an
increase in 45 was indicated by the results, suggesting the importance of the catalyst to
the coupling conversion rate.
Entry 5 would be used as a model for further experiments; increasing reaction
scale allowed isolation of the product in 51% yield, the highest thus far for the reaction.
This catalyst loading would be used for the synthesis because it returned high
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conversions without using a large amount of ligand. Yield appeared to be limited due to
product volatility, as Entry 4 appeared to go to 100% conversion but had a low yield.

Figure 11: Retrosynthetic strategy for the remaining reactions of synthetic path 3.

With one challenging transformation completed, the goal of the remainder of the
work of this total synthesis was to prepare the alkyl radical precursor, and initiate a
cyclization to form the fused ring system. Considering that 4-phenylpyrazole is volatile,
and the byproduct biphenyl should be inert under the alkylation and xanthate formation
conditions, the crude product was submitted without purification directly to the alkylation
reaction, avoiding loss by evaporation of 44. Scheme 21 outlines the results of this
synthesis.
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Scheme 21: A crude three-step sequence to form the xanthate ester from 4bromopyrazole.

This crude multi-step sequence proved to be effective with an excess of reagents
(8 equivalents KOH, 4 equivalents 3-chloro-1-propanol, 4 equivalents carbon disulfide,
10 equivalents methyl idodide) and the resulting xanthate ester was not volatile. The only
complications with this strategy were that the high mass of crude product mixture
contained relatively small amounts of desired product, so flash columns had to be
disproportionately large in order to handle the sample loading. While this strategy limited
waste by preventing the loss of the product to evaporation, it did not limit any waste in
the amount of solvent required for purification, and excess use of stoichiometric reagents.
The crude synthesis was only a minor step forward for green chemistry in this total
synthesis. The Suzuki coupling is a relatively green reaction due to its use of catalysis,
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and phenylboronic acid as a stable and innocuous reagent. The alkylation and xanthate
esterification reactions are less green. The alkylation uses 3-chloro-1-propanol which is
reasonably toxic, and the xanthate esterification uses carbon disulfide and methyl iodide,
which are both toxic. The xanthate esterification is therefore a limitation in carrying out
this synthesis. Supercritical fluid extraction would purify 44 with limited product loss,
allowing for the pure product to be submitted to the reaction, reducing the need for excess
reagents. Safe removal methods for carbon disulfide may clean up reaction waste and
make it easier to use a smaller column, limiting solvent waste. These methods were not
explored due to time constraints.
With the pure xanthate 37, the first attempt at radical cyclization was made. The
radical cyclization was designed to use 1,1-azobisisobutyronitrile with tributyltin hydride
in benzene, which are common conditions for radical transformations and well
documented for xanthate radical reactions.34-37 Yield was minimal, but the natural
product identified at the start of this project was finally made. Formation of the product
on the first attempt was encouraging, because precedent in the literature reports low
yields for this type of cyclization. The success of this reaction laid the groundwork for
improvements to make the reaction have higher conversion rates and potentially use more
green reagents. Flash chromatography was complicated by the presence of streaking
tributyltin hydride, so preparatory TLC was used to isolate the product with minor
impurities. The next attempt at this transformation sought to raise the total energy of the
reaction by using a less volatile solvent than benzene, in order to facilitate the 5-exo-trig
cyclization rate limiting step.
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Scheme 22: Radical cyclization of the xanthate ester using AIBN, SnBu3H, in benzene to
form withasomnine in <14% yield.

The proposed mechanism for this transformation involves using tributyltin
hydride as a radical initiator to cause the xanthate ester to fragment off and leave behind a
primary radical. The radical, which is highly reactive, should cyclize with the nearby
carbon atom at the 5-position. Fragmentation is highly unfavorable because it generates a
primary radical, but cyclization is also highly unfavorable because it breaks the
pyrazole’s aromaticity.

Figure 12: Proposed mechanism for the 5-exo-trig radical-initiated cyclization of 37 to 1.
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Regardless of which of these steps is rate-determining, both formation of a
primary radical and dearomatization of pyrazole are very high energy interactions.
Therefore, it was hypothesized that performing the reaction at a higher temperature
would effect the 5-exo-trig cyclization in higher conversion, or assist in initiating the
fragment that leads to the cyclization.
The reaction in toluene at reflux temperature with the more heat stable 1,1azobiscyclohexanecarbonitrile (ACCN) as a radical initiator was also performed (Scheme
23). The reaction appeared to result in degradation of the xanthate ester, and no formation
of product. It is likely that the xanthate ester degraded while 37 was in toluene at reflux
temperature, before the radical initiator mixture is slowly added to the reaction. This
proposal is corroborated by laboratory observations in which xanthates left on the bench
for long periods of time tended to show more degradation than those stored. The
following attempt explored using a peroxide in place of the toxic ACCN/HSnBu3
combination, following precedent of Zard et al.34, 36-37

Scheme 23: Attempted radical cyclization using ACCN, SnBu3H, in toluene to form
withasomnine, resulting in degradation of starting material.
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Use of a peroxide should generate radicals similar to AIBN of ACCN, but be
stable enough on its own to interact with the xanthate and fragment the radical. Benzoyl
peroxide was chosen as an initiator for its stability and reduced atom economy as well as
the fact that it was relatively inexpensive. The resulting byproduct should be benzoic
acid, which should be easily removable. However, when this was attempted with benzoyl
peroxide as the initiator (Scheme 24), 45 formed possibly as a result of phenyl radical
fragmentation driven by loss of carbon dioxide. The reaction only returned this product
and starting material.

Scheme 24: Attempted radical cyclization using benzoyl peroxide in benzene to form
withasomnine, resulting in formation of biphenyl.

With raising temperature of the reaction in an effort to increase the reaction’s
energy as an ineffective method of increasing yield, it was unclear as to how conversion
could be improved. It was also unclear as to how this reaction could be made into a green
staple of the synthesis by using peroxide initiators in place of toxic SnBu3H. Further
attempts to improve yield could be directed toward understanding the limits of the
xanthate ester in terms of heat stability. Increased energy to drive the cyclization is still a
reasonable hypothesis, so it may be possible to find a “sweet spot” that forms the product
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reasonably quickly without degrading the starting material to a considerable degree. Such
an experiment could consist of attempting the reaction at 10°C increments up from the
reflux temperature of benzene. Attempts at finding a green radical initiator could be an
exploration of different peroxides. Coupling of benzoyl peroxide to 45 could be a unique
problem to benzoyl peroxide, not the initiator itself. Zard et al. used lauroyl peroxide,
which may benefit in radical stabilization from the lengthy lauryl chain.34, 36-37
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CONCLUSIONS
The halogenation of pyrazoles by the in situ formation of electrophilic halogens is
an effective tool as a part of a synthetic arsenal. This work has demonstrated that the
formation of halogens through this method can be easily applied to pyrazole
halogenation.
Higher yields were apparently limited in some cases by product volatility. Using
an efficient purification method like supercritical fluid extraction may allow users of this
method to overcome the challenge of volatility relatively easily, and depending on the
mobile phase, it may be a more green way of purifying than standard flash
chromatography. Additionally, the acidic nature of oxone has shown, through this
synthesis, to be a limiting factor in terms of the sensitivity of functional groups to this
reaction’s conditions. For substrates with acid-sensitive functional groups, this reaction
may not be appropriate due to the possibility of degradation.
However, what this method lacks in functional group tolerance, it makes up in its
operational simplicity and overall green chemistry – byproducts are water soluble salts,
there is no energy input in the reaction, and potentially harmful solvents or reagents are
not necessary for the reaction. This method has the potential to be useful in total synthesis
where minimal environmental impact is desired. As demonstrated in the synthesis of
withasomnine, halogenated pyrazoles can be used to effect Suzuki chemistry or otherwise
functionalize the 4-position of the pyrazole ring. The common nature of pyrazoles in
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pharmaceuticals and agrochemicals convey the point that such syntheses may be common
in applications very close to human health.
The total synthesis of withasomnine has been completed. The challenging
transformation of a bromopyrazole to a phenylpyrazole has been overcome, which was a
significant hurdle in the completion of this synthesis. Likewise, alkylation and xanthate
ester formation proved to be relatively effective, and may only need some improvements
in yield to make a robust synthesis. Radical cyclization, the single most limiting factor of
the overall synthetic yield, has been successfully performed.
All steps of the synthesis need to be improved in method in order to afford higher
yields. Most of this work needs to be done in improving the overall yield of the
cyclization, so further experiments will be aimed at determining what steps of the
proposed radical mechanism are rate-limiting in order to effect the highest possible
conversion of the xanthate radical precursor to withasomnine.
The most pertinent experiments should be directed at determining the byproducts
of the cyclization and quantifying them in order to better understand which step is ratelimiting. High quantities of byproduct from fragmentation should indicate that
fragmentation is occurring, and should go to show that fragmentation is not the ratelimiting step. High quantities of 4-phenyl-1-propylpyrazole should indicate that the
cyclization is rate-limiting. Minor quantities of either may suggest that the fragmentation
is rate-limiting, and it is possible that adjustments could be made.
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To improve yield, other radical precursors could be explored, such as the
phenylselenide group. Experiments designed to improve yield will most likely also
include finding a temperature that does not cause rapid xanthate ester degradation but
promotes radical fragmentation and dearomatization. This should increase reaction
energy to more favorably form the product, while ideally avoiding degradation of the
starting material. This aspect of the synthesis is one of the least green parts due to its use
of toxic SnBu3H as a radical initiator, but this problem can be potentially circumvented
by using a peroxide initiator. Much of the recent work by Zard et al.35 used lauroyl
peroxide as radical initiator in place of AIBN or ACCN with tributyltin hydride. These
methods would be greener reactions, and would be a good strategy to pursue in the event
that fragmentation is indeed the issue. In order to improve this aspect of the synthesis,
different peroxides should be explored, with a range of stabilities that will ideally be able
to interact with and fragment the xanthate radical.
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EXPERIMENTAL
Unless otherwise specified, solvents were used as purchased from the
manufacturer. Hexanes for flash chromatography was distilled over CaH2 and Ethyl
Acetate (EtOAc) for flash chromatography was distilled. 1,4-Dioxane was distilled from
sodium and benzophenone. Dimethylformamide (DMF) was stored under nitrogen. All
reactions were monitored by tlc using Merck F254 Analytical Chromatography TLC silica
60 plates and visualized by UV light, iodine, or KMnO4 stain. Flash chromatography was
run using Selectra HI surface area silica (40-63 µm) according to the method described
by Still.43 NMR spectra were collected using a 400 MHz Varian-MR spectrometer. GCMS chromatograms and mass spectra obtained using HP 6890 Plus GC with FID and
5973 MSD on an open column, with samples injected by syringe as 3 μL, with 2 μL
pockets of air on either side. General settings for GC as follows: 200°C inlet temp, 200°C
detector temp, 1.0 mL/min flow rate.
General Procedure for Pyrazole Halogenation. To a flask, pyrazole substrate (3
mmol), deionized water (3 mL), and co-solvent (1.5 mL) were added and stirred together.
If the reaction did not involve co-solvent, no additional water was added. Sodium halide
(6 mmol) was added followed by Oxone (1.5 mmol). The flask was capped and stirred
constantly. On completion, the reaction mixture was quenched using portion-wise
addition of solid sodium metabisulfite until starch-iodide paper tested negative. The
remaining salts were dissolved by adding more deionized water (1-3 mL). The product
was extracted using 1:1 hexanes/ether (3 x 5 mL). The organic extract was dried with
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magnesium sulfate, then filtered and concentrated on rotary evaporator. Crude products
were purified using silica gel column chromatography.
4-Chloro-1-ethyl-3,5-dimethylpyrazole. (33a) Purified by flash chromatography (1.5 x
14.5 cm), 1:1 hexanes/Et2O eluent collecting 22 x 4 mL fractions. Eluted in fractions 810; analytical tlc, 1:1 hexanes/Et2O, Rf= 0.30. 50% yield as a yellow oil. IR (neat, cm-1)
2981.1, C-H; 1557, C=C; 1385.6, -CH3; 400 MHz NMR (CDCl3, ppm) δ 3.97 (2H, q, J=
7.1 Hz) 2.17 (3H, s) 2.15 (3H, s) 1.32 (3H, t, J= 7.4 Hz). 13C NMR (100.53 MHz, CDCl3,
ppm) δ 143.95, 134.40, 107.27, 44.59, 15.31, 11.22, 9.13.
4-Bromo-1-ethyl-3,5-dimethylpyrazole. (33b) Purified by flash chromatography (1.5 x
14.9 cm), 1:1 hexanes/Et2O eluent collecting 30 x 4 mL fractions. Eluted in fractions 712; analytical tlc, 1:1 hexanes/Et2O, Rf= 0.25. 11% yield as a yellow oil. IR (neat, cm-1)
2980.0, C-H; 1547.3, C=C; 1383.0, -CH3; 400 MHz NMR (CDCl3, ppm) δ 4.02 (2H, q,
J= 7.1 Hz) 2.21 (3H, s) 2.19 (3H, s) 1.34 (3H, t, J= 7.3 Hz). 13C NMR (100.53 MHz,
CDCl3, ppm) δ 145.58, 136.28, 93.74, 44.79, 15.38, 12.21, 10.12.
4-Chloro-1-allyl-3,5-dimethylpyrazole. (34a) Purified by flash chromatography (2 x
14.7 cm), 4:1 hexanes/EtOAc eluent collecting 60 x 5 mL fractions. Eluted in fractions
15-26; analytical tlc, 4:1 hexanes/EtOAc, Rf= 0.24. 36% yield as a yellow oil. IR (neat,
cm-1) 1557.7, C=C; 1385.4, -CH3; 400 MHz NMR (CDCl3, ppm) δ 5.89 (1H, dddd, J=
17.2, 10.5, 5.5, 5.5 Hz) 5.18 (1H, dddd, J= 10.5, 1.6, 1.6, 1.6 Hz) 4.99 (1H, dddd, J=
17.2, 1.6, 1.6, 1.6 Hz) 4.60 (2H, ddd, J= 5.5, 1.6, 1.6 Hz) 2.19 (3H, s) 2,17 (3H, s). 13C
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NMR (100.53 MHz, CDCl3, ppm) δ 146.03, 137.29, 132.61, 117.42, 94.22, 52.62, 12.24,
10.17.
4-Bromo-1-allyl-3,5-dimethylpyrazole. (34b) Purified by flash chromatography (2 x
14.9 cm), 2:1 hexanes/EtOAc eluent collecting 32 x 5 mL fractions. Eluted in fractions
10-15; analytical tlc, 2:1 hexanes/EtOAc, Rf= 0.35. 17% yield as a yellow oil. IR (neat,
cm-1) 1548.9, C=C; 1384, -CH3; 400 MHz NMR (CDCl3, ppm) δ 5.89 (1H, dddd, J=
17.0, 10.7, 5.5, 5.5 Hz) 5.18 (1H, dddd, J= 10.8, 1.6, 1.6, 1.6 Hz) 4.99 (1H, dddd, 17.0,
1.5, 1.5, 1.5 Hz) 4.62 (2H, ddd, J= 5.2, 1.6, 1.6 Hz) 2.20 (3H, s) 2.19 (3H, s). 13C NMR
(100.53 MHz, CDCl3, ppm) δ 146.02, 137.26, 132.61, 117.40, 94.20, 52.60, 12.23, 10.15.
4-Chloro-5-phenylpyrazole. (35a) Purified by flash chromatography (3 x 15.5 cm), 3:1
hexanes/EtOAc eluent collecting 40 x 10 mL fractions. Eluted in fractions 15-28;
analytical tlc, 3:1 hexanes/EtOAc, Rf= 0.21. 71% yield. IR (neat, cm-1) 3127.6, N-H ar;
3073.8, C-H ar; 1442.0, C-C; 1097.1, C-Cl. 400 MHz NMR (CDCl3, ppm) δ 10-12 (1H,
br s) 7.78 (2H, d, J= 7.6 Hz) 7.57 (1H, s) 7.4-7.5 (3H, m). 13C NMR (100.53 MHz,
CDCl3, ppm) δ 142.8 (br), 134.5 (br), 129.3, 128.81, 128.77, 127.2, 108.1.
4-Bromo-5-phenylpyrazole. (35b) Purified by flash chromatography (3 x 15.0 cm), 3:1
hexanes/EtOAc eluent collecting 50 x 10 mL fractions. Eluted in fractions 22-41;
analytical tlc, 3:1 hexanes/EtOAc, Rf= 0.22. 73% yield. mp= 114.0-117.5 ºC. IR (neat,
cm-1) 3108.7, N-H; 3066.7, C-H; 1436.4, C-C; 1099.1, C-Br. 400 MHz NMR (CDCl3,
ppm) δ 7.77 (2H, d, J= 8.1 Hz) 7.60 (1H, s) 7.3-7.5 (3H, m) 10-12 (1H, br s) 13C NMR
(100.53 MHz, CDCl3, ppm) δ 144.4 (br), 136.9 (br), 129.6, 128.9, 128.7, 127.6, 92.3.
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1-Benzyl-4-Bromopyrazole. (36) Purified by flash chromatography (1.5 x 15.0 cm), 2:1
hexanes/EtOAc eluent collecting 19 x 10 mL fractions Eluted in fractions 2-5; analytical
tlc, 2:1 hexanes/EtOAc, Rf= 0.37. 84% yield. IR (neat, cm-1) 1496.63, C-C; 713.08, C-H.
400 MHz NMR (CDCl3, ppm) δ 5.28 (2H, s) 7.2-7.5 (7H, m) 13C NMR (100.53 MHz,
CDCl3, ppm) δ 140.09 (br), 135.66, 129.58 (br), 128.95, 128.41, 127.88, 56.68.
4-Chloro-1-benzyl-3,5-dimethylpyrazole. (32) Purified by flash chromatography (1.5 x
15 cm), 4:1 hexanes/EtOAc eluent collecting 40 x 5 mL fractions. Eluted in fractions 4-8;
analytical tlc. 4:1 hexanes/EtOAc, Rf= 0.35. 57% yield as a yellow oil. 400 MHz NMR
(CDCl3, ppm) δ 7.2-7.3 (3H, m) 7.06 (2H, d, J= 7.6 Hz) 5.19 (2H, s) 2.22 (3H, s) 2.11,
(3H, s) 13C NMR (100.53 MHz, CDCl3, ppm) δ 144.532, 136.593, 135.493, 128.753,
127.699, 126.659, 108.103, 53.787, 11.347, 4.435.
4-Bromopyrazole. (24) Recrystallized from hexanes. 80% yield as white crystalline
solid, hydrate. m.p. 89.1-92.4 ºC. 400 MHz NMR (CDCl3, ppm) δ 7.69 (2H, s) 7.18-7.40
(3H, br s).
Procedure for Suzuki-Miyaura Coupling for 1H-pyrazoles. In the glove box under N2
atmosphere, CataCXium® A (0.06 mmol) was measured out into a conical vial fitted
with a septum along with a triangular stir bar. Outside the box, 4-bromopyrazole (0.60
mmol) and phenylboronic acid (0.75 mmol) were added to a glass pressure tube with a
stir bar and flushed with N2 for 20 minutes. Into a conical vial with a triangular stir bar,
Pd(OAc)2 (0.060 mmol) was added and flushed with N2 for 20 minutes. The contents of
the ligand vial were transferred to the Pd(OAc)2 vial by cannulation with distilled
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dioxane (2 x 0.75 mL) and the contents were stirred together. The contents of the vial
containing the mixed catalyst were transferred to the pressure tube by cannulation (2 x
1.5 mL). A solution of 1.2 M K2CO3 (1.5 mL, 1.8 mmol) in H2O was degassed for 30
minutes by purging with N2 and added by syringe to the vial containing the reactants and
catalyst. The septum on the pressure tube was quickly exchanged for a teflon cap, sealed,
and the tube was immersed in a 115 °C oil bath with constant stirring for 24 hours. The
pressure tube was removed from heat and allowed to return to r.t. The product was
filtered through a small pad of celite with 30 mL EtOAc, remaining water was separated
and extracted with 3 x 5 mL EtOAc. Extract was dried over MgSO4, filtered, and
concentrated down by rotary evaporator. The dried extract was used to determine
completion using GC-MS.
1H-3,5-dimethyl-4-phenylpyrazole. Obtained using 3.75% Pd(OAc)2 and 0.9%
CataCXium A. Workup performed by filtering through celite with 25 mL EtOAc.
Purified using flash chromatography in 1:2 hexanes/EtOAc, collecting 32 x 5 mL
fractions. Eluted in fractions 14-31; analytical tlc, 1:2 hexanes/EtOAc, Rf= 0.26. 35%
yield, white crystalline solid as hydrate. GC-MS (150°C): 11.356 min, m/z= 144 (M+),
117, 90. 400 MHz NMR (CDCl3, ppm) δ 7.42 (2H, t, J= 7.4 Hz) 7.24-7.34 (3H, m) 5.145.40 (3H, br s) 2.34 (6H, s).
1H-4-phenylpyrazole. (44) Purified using flash chromatography in 3:5 hexanes/EtOAc,
collecting 35 x 5 mL fractions. Eluted in fractions 9-20; analytical tlc, 3:5
hexanes/EtOAc, Rf= 0.33. 51% yield, white crystalline solid as hydrate. 400 MHz NMR
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(CDCl3, ppm) δ 7.62 (2H, d, J= 7.9 Hz) 7.35 (2H, t, J= 7.9 Hz) 7.19 (1H, t, J= 7.9 Hz)
2.93-4.34 (3H, br s).
Procedure for Alkylation and Xanthate Esterification of Pyrazole and 4Bromopyrazole. To an oven-dried flask fitted to a cold-water condenser, pyrazole (3.62
mmol) and powdered KOH (4.63 mmol, 0.2616 g) were added. The apparatus was
flushed with N2 for 15 minutes and dry DMF (43 mL) was added by syringe. The flask
was immersed in an oil bath at 50 °C and the solution was constantly stirred. After 10
minutes, 3-chloro-1-propanol (4.63 mmol, 0.334 mL) was added by syringe. After
starting materials were not visible by tlc, the flask was removed from heat and cooled to
room temperature. Carbon disulfide was added by syringe (7.42 mmol, 0.438 mL). To the
flask, powdered KOH was added by quickly breaking the seal on the condenser (7.26
mmol, 0.4075g). To the flask, CH3I was added by syringe (7.24 mmol, 0.451 mL) and the
mixture was allowed to react at r.t. until the intermediate product no longer visible by tlc.
The salts were dissolved using 10 mL deionized H2O. The product was extracted in 3 x
50 mL EtOAc and 3 x 30 mL DCM. The combined organic layers were washed with 3 x
150 mL H2O. The organic layer was dried over MgSO4, filtered, and concentrated on a
rotary evaporator.
O-(3-(1H-pyrazol-1-yl)propyl) S-methyl carbonodithioate. (40) Purified using flash
chromatography (3 x 14.9 cm), 2:1 hexanes/EtOAc, collecting 40 x 15 mL fractions.
Eluted in fractions 10-19; analytical tlc, 2:1 hexanes/EtOAc, Rf= 0.31. 71% yield as a
yellow oil. 400 MHz NMR (CDCl3, ppm) δ 7.50 (1H, d, J= 1.6 Hz) 7.36 (1H, d, J= 2.4
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Hz) 6.22 (1H, t, J= 2.2 Hz) 4.54 (2H, t, J= 6.1 Hz) 4.25 (2H, t, J= 6.9 Hz) 2.55 (3H, s)
2.35 (2H, ddd, J= 12.8, 6.4, 6.4 Hz) 13C NMR (100.53 Hz, CDCl3, ppm) δ 215.82,
139.69, 129.41, 105.48, 70.43, 48.51, 29.13, 19.13.
O-(3-(4-bromo-1H-pyrazol-1-yl)propyl) S-methyl carbonodithioate. (38) Purified
using flash chromatography (3 x 15.0 cm), 4:1 Hexanes/EtOAc, collecting 40 x 20 mL
fractions. Eluted in fractions 6-14; analytical tlc, 4:1 hexanes/EtOAc, Rf= 0.39. 55%
yield as a yellow oil. IR (neat, cm-1) 1208.73, C-O-C; 1057.51, C=S.400 MHz NMR
(CDCl3, ppm) δ 7.48 (1H, s) 7.42 (1H, s) 4.59 (2H, t, J= 6.1 Hz) 4.24 (2H, t, J= 6.8) 2.57
(2H, s) 2.36 (3H, p, J= 6.13 Hz).
Procedure for Suzuki-Miyaura Coupling, Alkylation, and Xanthate Esterification of
4-bromopyrazole. In the glove box under N2 atmosphere, CataCXium® A (0.158 mmol,
0.0567 g) was measured out into a conical vial fitted with a septum along with a
triangular stir bar. Outside the box, 4-bromopyrazole (1.58 mmol, 0.2464 g) and
phenylboronic acid (1.97 mmol, 0.2408 g) were added to a glass pressure bomb with a
stir bar and flushed with N2 for 6 hours, then dissolved in 3.05 mL distilled dioxane. Into
a conical vial with a triangular stir bar, Pd(OAc)2 (0.078 mmol, 0.0175 g) was added and
flushed with N2 for 30 minutes. The contents of the ligand vial were transferred to the
Pd(OAc)2 vial by cannulation with distilled dioxane (2 x 1.5 mL) and stirred together.
The contents of the vial containing the mixed catalyst were transferred to the pressure
tube by cannulation (2 x 3.0 mL). A solution of 1.2 M K2CO3 (3.95 mL, 7.1 mmol) in
H2O was degassed for 30 minutes by purging with N2 and added by syringe to the vial
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containing the reactants and catalyst. The septum on the pressure tube was quickly
exchanged for a teflon cap, sealed, and the tube was immersed in a 115 °C oil bath with
constant stirring for 24 hours. The pressure tube was removed from heat and allowed to
return to r.t. The product was filtered through a small pad of celite with 30 mL EtOAc,
remaining water was separated and extracted with 3 x 5 mL EtOAc. The organic layers
were combined and dried over MgSO4, filtered, and concentrated down by rotary
evaporator. To an oven-dried flask fitted to a cold-water condenser, the crude extract and
powdered KOH (2.05 mmol, 0.1150 g) were added. The apparatus was flushed with N2
for 15 minutes and dry DMF (18.8 mL) was added by syringe. The flask was immersed in
an oil bath at 50 °C and the solution was constantly stirred. After 10 minutes, 3-chloro-1propanol (2.08 mmol, 0.150 mL) was added by syringe. After 4 days, monitoring by tlc
and GC-MS indicated the presence of starting materials, so powdered KOH (1.57 mmol,
0.0885 g) and 3-chloro-1-propanol (1.58 mmol, 0.114 mL) were added. After 5 days,
monitoring by tlc and GC-MS indicated the presence of starting materials, so powdered
KOH (1.62 mmol, 0.0908 g) and 3-chloro-1-propanol (1.58 mmol, 0.114 mL) were
added. After starting materials were not visible by tlc or GC-MS, the flask was removed
from heat and cooled to room temperature. Carbon disulfide was added by syringe (6.77
mmol, 0.409 mL). To the flask, powdered KOH was added by quickly breaking the seal
on the condenser (6.88 mmol, 0.3861 g). To the flask, CH3I was added by syringe (13.5
mmol, 0.824 mL) and allowed to react at r.t. After 4 days following the addition of the
last reagent, the intermediate product was no longer visible by tlc. The salts were
dissolved using 10 mL deionized H2O. The product was extracted in 3 x 30 mL EtOAc
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and 3 x 30 mL DCM. The combined organic layers were washed with 5 x 100 mL H2O.
The organic layer was dried over MgSO4, filtered, and concentrated on rotary evaporator.
O-(3-(4-phenyl-1H-pyrazol-1-yl)propyl) S-methyl carbonodithioate. (37). Purified
using flash chromatography (3 x 15.0 cm), 2:1 Hexanes/EtOAc, collecting 36 x 15 mL
fractions. Eluted in fractions 11-13; analytical tlc, 2:1 hexanes/EtOAc, Rf= 0.32. 45%
yield from 4-bromopyrazole as a yellow oil. IR (neat, cm-1) 1212.36, C-O-C; 1058.66,
C=S. 400 MHz NMR (CDCl3, ppm) 400 MHz NMR (CDCl3, ppm) δ 7.80 (1H, s) 7.64
(1H, s) 7.47 (2H, d, J= 7.5 Hz) 7.36 (2H, t, J= 7.5 Hz) 7.23 (2H, t, J= 7.5 Hz) 4.63 (2H, t,
J= 5.8 Hz) 4.30 (2H, t, J= 6.8 Hz) 2.57 (3H, s) 2.42 (2H, p, J= 6.3 Hz).
Procedure for Radical-initiated Cyclization. To an oven-dried flask, 0.13 mmol of O(3-(4-phenyl-1H-pyrazol-1-yl)propyl) S-methyl carbonodithioate (37) was added, and
the flask was fitted with a condenser. After purging with N2, the pyrazole was dissolved
in degassed benzene (150 mL) and the flask was immersed in a constant-temperature oil
bath at 80ºC. To a separate flask, AIBN was added (0.17 mmol) and dissolved in
degassed benzene (30 mL). After dissolution, SnBu3H was added to this flask by syringe
and the solution was mixed together. The solution containing AIBN and SnBu3H was
added manually over the course of four hours by syringe to the heated solution containing
the pyrazole at a rate of 1.2 mL/10 min. The mixture was kept on heat overnight. The
next day, benzene was removed by rotary evaporator, and the product was isolated by
flash chromatography in 4:1 hexanes/EtOAc, then withasomnine (1) was separated from
other contaminants by preparatory TLC in 2:1 benzene/EtOAc, analytical tlc, Rf= 0.23.
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14% yield as a white solid. GC-MS (150°C/5 min, 200°C): 15.117 min, m/z= 184 (M+),
129, 77 (Ph). 400 MHz NMR (CDCl3, ppm) δ 7.45 (2H, d, J= 8.3 Hz) 7.37 (2H, t, J= 8.3
Hz) 7.20 (1H, t, J= 8.3 Hz) 4.22 (2H, t, J= 8.1 Hz) 3.12 (2H, t, J= 8.1 Hz) 2.71 (2H, p, J=
8.1).
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Appendix 1: 1H NMR Spectrum of 33a.
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Appendix 2: 1H NMR Spectrum of 33b.
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Appendix 3: 1H NMR Spectrum of 34a.
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Appendix 4: 1H NMR Spectrum of 34b.
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Appendix 5: 1H NMR Spectrum of 35a.
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Appendix 6: 1H NMR Spectrum of 35b.
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Appendix 7: 1H NMR Spectrum of 36.
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Appendix 8: 1H NMR Spectrum of 32.
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Appendix 9: 1H NMR Spectrum of 24.
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Appendix 10: 1H NMR Spectrum of 40.
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Appendix 11: 1H NMR Spectrum of 38.
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Appendix 12: 1H NMR Spectrum of 3,5-dimethyl-4-phenylpyrazole.
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Appendix 13: 1H NMR Spectrum of 44.
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Appendix 14: 1H NMR Spectrum of 37.
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Appendix 15: 1H NMR Spectrum of 1.
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Appendix 16: 13C NMR Spectrum of 33a.
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Appendix 17: 13C NMR Spectrum of 33b.
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Appendix 18: 13C NMR Spectrum of 34a.
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Appendix 19: 13C NMR Spectrum of 34b.
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Appendix 20: 13C NMR Spectrum of 35a.
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Appendix 21: 13C NMR Spectrum of 35b.
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Appendix 22: 13C NMR Spectrum of 36.
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Appendix 23: 13C NMR Spectrum of 40.
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Appendix 24: 13C NMR Spectrum of 38.
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Appendix 25: 13C NMR Spectrum of 37.
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Appendix 26: IR Spectrum of 33a.
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Appendix 27: IR Spectrum of 33b.
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Appendix 28: IR Spectrum of 34a.
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Appendix 29: IR Spectrum of 34b.
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Appendix 30: IR Spectrum of 35a.
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Appendix 31: IR Spectrum of 35b.
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Appendix 32: IR Spectrum of 36.
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Appendix 33: IR Spectrum of 40.
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Appendix 34: IR Spectrum of 38.
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Appendix 35: IR Spectrum of 37.
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